Download
https://www.ndtvprofit.com/business/biocon-gets-3-usfda-observations-for-insulin-facility-in-malaysia?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Biocon has received three observations from the U.S. FDA following inspection of its insulin manufacturing facility in Malaysia.
Share